TARS - Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease.
As of May 15, 2026: spot at $62.39, ATM IV 54.2%, max pain $70.00, net GEX -$414.4K.
- Sector
- Healthcare
- Industry
- Biotechnology
- Market Cap
- $2.78B
- Beta
- 0.53
- 52-Week Range
- 38.51-85.25
- CEO
- Bobak R. Azamian
- Employees
- 323
- IPO Date
- Oct 16, 2020
- Exchange
- NASDAQ
What TARS Looks Like to Options Traders Today
IV rank of 8.7% is subdued relative to the 1-year history, conditions that typically favor premium-buying or long-volatility structures (debit spreads, calendar spreads, long straddles); negative net gamma exposure (-$414.4K) means dealers hedge with trend, amplifying realized volatility and accelerating directional moves; the 25-delta skew (-0.074) prices puts richer than calls, the typical equity downside-protection skew.
What This Page Covers
The TARS overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.
Frequently asked TARS overview questions
- What is TARS?
- TARS is the ticker symbol for Tarsus Pharmaceuticals, Inc., a listed security. Tarsus Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Listed on NASDAQ. TARS is the equity ticker shown on this page; equity options traders use the security for directional, volatility, and income strategies via the listed options chain.
- What does the TARS options snapshot look like today?
- As of May 15, 2026, the TARS options snapshot shows spot at $62.39, ATM IV 54.2%, IV rank 8.7%, max pain $70.00, net GEX -$414.4K, expected move 15.54%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are TARS's key statistics?
- Tarsus Pharmaceuticals, Inc. (TARS) carries a market capitalization of $2.78B, beta of 0.53 relative to the broader market, 52-week range of 38.51-85.25. Full income statement, balance sheet, cash flow, and TTM ratio history is on the per-ticker fundamentals page; daily price history and 52-week levels are accessible from the same view. These structural inputs frame how the options market prices implied volatility around earnings windows and capital events.
- What sector or industry does TARS belong to?
- Tarsus Pharmaceuticals, Inc. operates in the Healthcare sector, in the Biotechnology industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare TARS's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the TARS data on this page?
- The options snapshot above is dated May 15, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Company-profile fields (sector, industry, market cap, P/E, IPO date) refresh from the vendor feed nightly. Financials and earnings refresh as 10-K and 10-Q filings are parsed (typically within several business days of the actual report). FINRA microstructure data refreshes on the source's cadence (daily for short volume, bi-monthly for short interest, weekly for the OTC volume file, twice-monthly for SEC FTD).